Skip to main content
. 2023 May 16;45(5):2757–2768. doi: 10.1007/s11357-023-00818-1

Table 5.

Reported frequency of potentially negative health conditions experienced in the past 3 months by survey respondents. Only rapamycin users who had been taking rapamycin for at least 90 days (n = 245) were included in this analysis. False discovery rate (FDR) adjusted p-values shown. Shading indicates p < 0.05 with green being more frequent in non-users and yellow being more frequent in rapamycin users

graphic file with name 11357_2023_818_Tab5_HTML.jpg